Skip to main content
Top
Published in: Pituitary 2/2006

01-06-2006 | Case Report

Acromegaloidism with normal growth hormone secretion associated with X-Tetrasomy

Authors: Paula Álvarez-Vázquez, Alberto Rivera, Irene Figueroa, Concepción Páramo, Ricardo V. García-Mayor

Published in: Pituitary | Issue 2/2006

Login to get access
Metadata
Title
Acromegaloidism with normal growth hormone secretion associated with X-Tetrasomy
Authors
Paula Álvarez-Vázquez
Alberto Rivera
Irene Figueroa
Concepción Páramo
Ricardo V. García-Mayor
Publication date
01-06-2006
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 2/2006
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-006-9330-0

Other articles of this Issue 2/2006

Pituitary 2/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine